FDA Announces Joint Meeting of Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss various topics related to arthritis and drug safety, with the meeting set to take place on an upcoming date.